Synthesis and anticancer activity of a series of norcantharidin analogues
- 1 August 2012
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 54, 573-581
Abstract
No abstract availableKeywords
Funding Information
- Australian Research Council
- University of Newcastle
This publication has 28 references indexed in Scilit:
- Norcantharimide analogues possessing terminal phosphate esters and their anti-cancer activityBioorganic & Medicinal Chemistry, 2011
- Synthesis of heterocyclic substituted norcantharidin derivativesJournal of Heterocyclic Chemistry, 2011
- Synthesis and biological activity of Δ-5,6-norcantharimides: importance of the 5,6-bridgeEuropean Journal of Medicinal Chemistry, 2010
- Structural Basis of Serine/Threonine Phosphatase Inhibition by the Archetypal Small Molecules Cantharidin and NorcantharidinJournal of Medicinal Chemistry, 2009
- Norcantharidin Analogues: Synthesis, Anticancer Activity and Protein Phosphatase 1 and 2A InhibitionChemMedChem, 2008
- Norcantharimides, synthesis and anticancer activity: Synthesis of new norcantharidin analogues and their anticancer evaluationBioorganic & Medicinal Chemistry, 2007
- Heterocyclic substituted cantharidin and norcantharidin analogues—synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activityBioorganic & Medicinal Chemistry Letters, 2007
- Anhydride modified cantharidin analogues: synthesis, inhibition of protein phosphatases 1 and 2A and anticancer activityBioorganic & Medicinal Chemistry Letters, 2000
- Effects of norcantharidin, a protein phosphatase type-2A inhibitor, on the growth of normal and malignant haemopoietic cellsEuropean Journal of Cancer, 1995
- Poisoning by CantharidinBMJ, 1954